David A. Pierce - 01 Jun 2021 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP Pres MedSurg
Signature: /s/ Vance R. Brown, Attorney-in-fact
Issuer symbol: BSX
Transactions as of: 01 Jun 2021
Net transactions value: -$56,625
Form type: 4
Filing time: 02 Jun 2021, 16:20:35 UTC
Next filing: 07 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+2,973	+145%	$0.000000	5,030	01 Jun 2021	Direct	F1
transaction	BSX	Common Stock	Tax liability	$56,625	-1,319	-26%	$42.93	3,711	01 Jun 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-2,973	-100%	$0.000000^*	0	01 Jun 2021	Common Stock	2,973		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Shares of common stock will be issued to the reporting person in five equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant.